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USA300 is a pandemic clonal lineage of hypervirulent, community-
acquired, methicillin-resistant Staphylococcus aureus (CA-MRSA) with
specific molecular characteristics. Despite its high clinical relevance,
the evolutionary origin of USA300 remained unclear. We used com-
parative genomics of 224 temporal and spatial diverse S. aureus iso-
lates of multilocus sequence type (ST) 8 to reconstruct the molecular
evolution and global dissemination of ST8, including USA300. Analy-
ses of core SNP diversity and accessory genome variations showed
that the ancestor of all ST8 S. aureus most likely emerged in Central
Europe in the mid-19th century. From here, ST8 was exported to
North America in the early 20th century and progressively acquired
the USA300 characteristics Panton–Valentine leukocidin (PVL),
SCCmec IVa, the arginine catabolic mobile element (ACME), and a
specific mutation in capsular polysaccharide gene cap5E. Although
the PVL-encoding phage ϕSa2USA was introduced into the ST8 back-
ground only once, various SCCmec types were introduced to ST8 at
different times and places. Starting from North America, USA300
spread globally, including Africa. African USA300 isolates have aber-
rant spa-types (t112, t121) and form a monophyletic group within the
clade of North American USA300. Large parts of ST8 methicillin-
susceptible S. aureus (MSSA) isolated in Africa represent a symplesio-
morphic group of ST8 (i.e., a group representing the characteristics of
the ancestor), which are rarely found in other world regions. Isolates
previously discussed as USA300 ancestors, including USA500 and a
“historic” CA-MRSA from Western Australia, were shown to be only
distantly related to recent USA300 clones.
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The bacterium Staphylococcus aureus is an opportunisticpathogen that has the ability to colonize the skin and mucous
membranes of humans and different animal species. It may
cause mild to severe diseases, ranging from superficial wound
infections or food poisoning to bacteremia and other systemic
infections (1, 2). Multidrug resistance dramatically compli-
cates infection treatment and can cause fatal outcomes. Es-
pecially, methicillin-resistant S. aureus (MRSA) is of major
concern for public health. MRSA used to be limited to the
hospital environment but has increasingly been identified in
community-acquired (CA) infections within the past two de-
cades. CA-MRSA isolates usually belong to particular clonal
lineages and possess comparatively small staphylococcal cas-
sette chromosome mec (SCCmec) elements of types IV or V
(MRSA-IV/V), which confer methicillin resistance and the
phage-encoded toxin Panton–Valentine leukocidin (PVL),
which seems to play a role in enhanced skin and soft tissue
infections (2). There are major variations in the spatial and
temporal population structures and global distribution of CA-
MRSA, with different clones dominating in different world
regions (3–7). However, one clone is found worldwide in re-
gionally varying frequencies: the multilocus sequencing
(MLST) sequence type (ST) 8-MRSA-IV “USA300.”
USA300 is a hypervirulent clone that was first identified in the
United States around the turn of the millennium (8). Initially, it
was mainly isolated from certain risk groups, including athletes,
children, prisoners, and military recruits (9–11), but soon spread
epidemically in the general population and eventually became
the dominant CA-MRSA circulating in North America (8, 12).
In 2003, it was termed “USA300” based on its characteristic
pulsed-field gel electrophoresis (PFGE) pattern (13). Moreover,
the “classical” USA300 clone is characterized by specific genetic
features: association with ST8 and spa-type t008, lack of a
functional capsular polysaccharide due to point mutations in
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genes cap5D and cap5E (14), and possession of SCCmec IVa,
PVL-encoding genes lukF-PV and lukS-PV, and the arginine
catabolic mobile element (ACME) (8, 15). This clone is some-
times referred to as “USA300-0114” (12).
The epidemiology of ST8/USA300 differs remarkably among
world regions. In Europe, ST8 is a common CA-MRSA, but
most of them are non-USA300 (3). Repeated introductions of
USA300 to the European population have been shown (16–18);
however, the clone does not seem to spread in the general
population. ST8 is very rare in Asia (4), with sporadic findings of
USA300 reported from Japan (19), South Korea (20), and
Pakistan (21). The clone CA-MRSA/J gained some attention in
Japan over the past years; however, this clone was suggested to
have evolved from a Japanese HA-MRSA rather than the classic
USA300 (22). ST8 is also no major clone in the Asia-Pacific re-
gion, including Australia and New Zealand (5), although there are
early reports of ST8 CA-MRSA from remote settlements in
Western Australia (23–25). Since 2006, USA300 has also been
increasingly detected in South American countries (26). Despite
the concordant PFGE patterns, USA300 isolates from South
America were found to possess different molecular features,
compared with USA300-0114, including an SCCmec IVc element
and a mobile genetic element conferring copper and mercury re-
sistance (COMER) instead of ACME (27). The North and South
American variants are now considered as two distinct genetic
lineages termed USA300-NAE for “North American Epidemic”
and USA300-SAE for “South American Epidemic” (27) (or
USA300-LV for “Latin American Variant”) (12). Both lineages
shared a common ancestor ∼40 y ago (27). However, the geo-
graphic and evolutionary origin of this ancestor is still unclear.
One suggested scenario hypothesized the evolution of USA300
from the North American HA-MRSA lineage USA500 (ST8-
MRSA-IV), with subsequent acquisition of PVL and ACME (28).
However, more recent genome-based analyses rather suggest the
evolution from PVL-positive CA–methicillin-susceptible S. aureus
(CA-MSSA) (27). Consequently, detection of high rates of PVL-
positive ST8-MSSA in Trinidad and Tobago gave reason to
speculate about a Caribbean origin of the USA300 lineage (29).
When high rates of PVL-positive ST152-MSSA were detected in
Haiti, their origin was linked with sub-Saharan Africa (SSA) be-
cause many people from the Caribbean have African ancestry (30,
31) and PVL is known to be present in SSA in very high rates (6, 7,
32). Like ST152, ST8 is a widespread clone in SSA. Even sporadic
findings of USA300-like PVL- and ACME-positive ST8-MRSA-
IV were reported from Cameroon (n = 1) (33), Gabon (n = 6)
(34–37), Ghana (n = 1) (38), and two Swiss patients with travel or
immigration history to/from Cameroon and Sierra Leone (17).
However, most of these African isolates (9/10) did not belong to
the classic USA300 spa-type t008, but to the closely related spa-
types t112 (n = 3) and t121 (n = 6). Consequently, it was not
certain if the African ST8 isolates shared the same evolutionary
history as the North American USA300, or whether they had
evolved from a local “African” S. aureus population. SSA was
shown before to be the origin of a pandemic CA-MRSA lineage
(CC80) (39). Thus, we have reason to hypothesize an African
origin of the pandemic USA300 lineage. We focused our research
on countries of SSA instead of including the entire African con-
tinent. This was done because the North Africa/Maghreb region is
culturally and genetically stronger connected to Southern Europe
and the Middle East than to African countries south of the Sahara
(40). The division of the African continent into “North Africa”
and “sub-Saharan Africa” also complies with United Nations
classification schemes (https://unstats.un.org/unsd/methodology/
m49/, accessed April 5, 2017). In this study, we performed whole
genome sequencing (WGS) analysis of 224 diverse global ST8
isolates, allowing the interpretation of the temporal and spatial
evolution of USA300.
Results
We performed whole genome sequencing (WGS) of 224 S. aureus
isolates aimed to represent the genetic diversity of ST8 over space
and time. These isolates differed in 12,403 (12,469 prepurging)
core genome single nucleotide polymorphisms (SNPs). The con-
catenated SNPs were used to reconstruct the temporal and spatial
evolution of S. aureus USA300 using maximum-likelihood (ML)
(Fig. 1) and Bayesian statistics (Fig. 2). All major splits were
supported by high bootstrap and posterior support values (Figs.
S1C and S2).
ST8 Emerged from Central Europe, USA300 from North America. Both
phylogenies confirm the separation of USA300 into two distinct
lineages, USA300-NAE and USA300-SAE, which shared a
common ancestor around 50 y ago [median 1967, highest prob-
ability density (HPD) 95%, 1963 to 1971]. All isolates with gene
combinations characteristic for USA300-NAE and USA300-
SAE, such as ACME, COMER, and cap5E mutations, were
exclusively found in these two clades, confirming the exclusivity
of these genetic combinations within the ST8 lineage (Fig. 1 and
Dataset S1). However, partial elements of ACME and COMER
were also found in isolates from other phylogenetic clades, albeit
in different allelic variants. Nevertheless, we did not find evi-
dence for successful spread of those clones possessing single
genes of ACME or COMER. This indicates that, if these ele-
ments indeed confer an evolutionary advantage, as it was sug-
gested in previous studies (15, 41), it is presumably the specific
combination of genes or regulatory mechanisms that facilitate
the success of USA300. According to our results, USA300-NAE
acquired ACME, SCCmec IVa, and the cap5E mutation
Asp75Tyr in the late 1980s (median 1989, HPD 95%, 1987 to
1991) (Fig. 2) while USA300-SAE acquired SCCmec IVc and the
COMER element some years earlier (median 1980, HPD 95%,
1977 to 1983) (Fig. S1).
Our Results Suggest a Single Introduction of the PVL-Phage ϕSa2USA
and Various Introductions of Different SCCmec Elements to the ST8
Background. First, we determined the sequences of the PVL-
encoding genes lukF-PV and lukS-PV, which were identical
among all isolates (n = 120), except for one nonsynonymous SNP
(Tyr208Cys) in lukF-PV in one Swiss isolate (Switzerland_2013_2).
Reference mapping was performed for all isolates with available
read data (66 of 120 isolates). Considering the results of both as-
sembly methods, ϕSa2USA (5,189 bp, GenBank accession no.
KX130855.1) and its 300 nucleotides 3′ and 5′ flanking regions
were identified in all 120 samples. The exact reference sequence
was identified in 95 samples, 19 samples possessed allelic variants
with one to four point mutations, and five samples possessed
allelic variants with frameshift mutations. In one isolate (Colom-
bia_2006_4), 25 point mutations were identified within a stretch of
193 nucleotides. National Center for Biotechnology Information
(NCBI) BLAST results suggested a recombination event, in which
a part of the S. aureus peptidoglycan hydrolase gene was integrated
into the ϕSa2USA amidase gene. The recombinant sequence and
flanking regions, respectively, were identical to the peptidoglycan
hydrolase and amidase genes of isolate CA12 (CP007672.1,
Colombia_2007_2), which originates from the same region as
Colombia_2006_4. As all flanking regions of the ϕSa2USA were
identical in all isolates, our results suggest a single introduction of
the PVL-phage ϕSa2USA to the ST8 background, which is in
contrast to multiple introductions of different SCCmec elements at
various times and places. Specifically, except for SCCmec IVa and
IVc, we also identified six SCCmec IVb isolates from the United
States (n = 5) and Austria (n = 1), two SCCmec IVd isolates from
Australia (n = 1) and the United States (n = 1), eight SCCmec IVg
isolates from the United States (n = 5) and Gabon (n = 3), two
SCCmec IVi isolates from the United States, and one SCCmec V
isolate from Australia (Dataset S1).















African USA300 and ST8 Isolates Are Unique. All 10 African isolates
previously described as USA300-like (ST8-MRSA, PVL-positive,
ACME-positive, spa types t112 or t121) (17, 33–38) were found
within the phylogenetic clade of USA300-NAE and could con-
sequently be confirmed to be “true” USA300-NAE isolates,
despite their non-t008 spa-types (Figs. 1 and 2). Noteworthy,
nine of these isolates, collected in Gabon (n = 6), Cameroon
(n = 2), and Ghana (n = 1), formed one distinct monophyletic
“African USA300” clade, indicating a single introduction event
to the African continent, followed by spread in the local pop-
ulation. In addition to these nine isolates previously described as
USA300-like, six PVL- and ACME-positive isolates from Gabon
also fell into this monophyletic African clade (Fig. 2). Our
results indicate a transmission from the United States to
Gabon in 1996 (HPD 95%, 1994 to 1997) (Figs. 2 and 3). All
monophyletic African USA300 isolates belonged to spa-types
t121 (n = 12) or t112 (n = 3). The only “nonmonophyletic”
African USA300 isolate had spa-type t008 and was isolated in
Switzerland from a person with travel or immigration history
to/from Sierra Leone. This suggests that the epidemiological
link to Sierra Leone was wrong and that this isolate should
rather be considered as European.
No African ST8 isolate was found in direct ancestry to the
USA300 clades, consequently ruling out the hypothesized evo-
Fig. 1. Maximum-likelihood phylogeny of 224 ST8 S. aureus isolates based on 12,403 core genome single nucleotide polymorphisms. The colors represent the
region of origin of each sample. Phylogenetic positions of the included NCBI RefSeq genomes (two USA300 and one USA500) are highlighted with asterisks.
Information about the complete presence (black squares), partial presence (gray squares), or absence (white squares) of USA300-specific genetic features is
given for each sample. Major genetic introduction events are indicated on the respective phylogenetic branches. (Scale bar: substitution per site.)
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lution of USA300 from SSA (Fig. 2). Likewise, USA500 and the
aboriginal CA-MRSA from Western Australia were found in
different phylogenetic clades and shared a common ancestor
with USA300 that circulated in Central Europe ∼100 y ago. The
Fig. 2. Bayesian maximum clade credibility tree calculated from 10,801 sampled trees. Branch colors represent the country of origin of each sample and their
most recent common ancestor (MRCA), respectively. Major clade’s MRCA origins are verbalized using international country codes. Important groups like
USA300 or the “Basal African” clade are highlighted with gray squares (annotation in bold). Time periods and age of clades can be inferred using the timeline
at the bottom. The most recent isolate was collected in 2013; the MRCA of all isolates was dated to 1854 (HPD 95%, 1841 to 1865). MSSA, methicillin-
susceptible S. aureus; PVL+, Panton–Valentine leukocidin positive; USA300-NAE, North American Epidemic USA300 clone; USA300-SAE, South American
Epidemic USA300 clone. Detailed divergence timings and countries for each node are displayed in Fig. S1.















isolates basal to both USA300 lineages comprised mainly PVL-
positive (20/21) MRSA (n = 12) and MSSA (n = 9) from the
United States (n = 11), Colombia (n = 2), Germany (n = 2), and
Trinidad and Tobago (n = 6). The most recent common ancestor
(MRCA) of all these isolates apparently circulated in the United
States around 1940 (median 1939, HPD 95%, 1932 to 1946)
(Fig. 2). However, North America does not appear to be the origin
of the entire ST8 clone. Instead, our results suggest an emergence
of ST8 in Europe during the mid-19th century (Denmark, 93.2%;
median 1854, HPD 95%, 1841 to 1865).
Around 1900 (median 1900, HPD 95%, 1892 to 1907), the
shortened cap5D allele (frameshift mutation in nucleotide po-
sition 994) (14) (Dataset S2) arose and spread in the European
ST8 population. In the early 20th century, one cap5D-mutated
European ST8 MSSA strain was exported to the United States,
where it spread and diversified before eventually evolving into
the epidemic USA300 clone by stepwise acquisition of PVL,
ACME, and the cap5E mutation (Fig. 3). Later, this clone was
reintroduced to Europe on multiple occasions (16, 17, 42).
Before the spread of the mutated cap5D in the European
ST8 population, one isolate with WT cap5D was exported to Gabon
around 1920 and founded a symplesiomorphic, mainly “African”
ST8 sublineage (MRCA, Gabon, 1922, HPD 95%, 1912 to 1930)
(Fig. 2). “Symplesiomorphic” means that this group does not pos-
sess any “derived” characteristics, like PVL or ACME, but repre-
sents the state of the common ancestor. The African clone spread
and diversified in the Gabonese population and was transmitted to
other SSA countries, including Côte d’Ivoire, the Democratic Re-
public of Congo, and Tanzania, as well as to Australia and Trinidad
and Tobago (Fig. 2).
Identification of Markers for USA300. We screened our collection
for the unique presence or absence of genes and group-specific
nonsynonymous SNPs for USA300-NAE, USA300–SAE, and the
African USA300 clade (Fig. 2), respectively. Within our collection,
no yet unknown USA300-specific unique genetic markers were
found for the first two groups; for the African USA300 clade,
however, we identified five nonsynonymous SNPs that were present
in all 15 isolates of this clade in comparison with all other isolates
investigated (Table 1).
Discussion
The results and findings presented here shed light on the evolution
of S. aureus ST8 and USA300. Our findings show that direct evo-
lution of USA300 from USA500 is unlikely because their last
common ancestor circulated in Europe around 100 y ago (Fig. 2).
This corroborates previous findings (16, 27, 43). Similarly, direct
evolution from ST8 CA-MRSA isolated from indigenous people in
Western Australia, or PVL-positive MSSA from Trinidad and
Tobago or Western Africa, was not supported by our data (Figs. 2
and 3 and Fig. S1). Instead, the most likely origin of USA300-NAE
and USA300-SAE was calculated to be PVL-positive MSSA cir-
culating within the United States. The respective PVL-negative
ST8 ancestor appears to have been imported from Europe in the
early 20th century during an era of increased emigration of people
from Europe to the United States due to war, economic crisis, and
political persecution (Fig. 3 and Fig. S1). This confirms the findings
of Planet et al. (27), who stated that “members of the USA300 have
been present in the Western hemisphere since the 1930’s.” Other
pandemic S. aureus clones have likewise been shown to have orig-
inated in Europe: for example, ST22 EMRSA-15 (44).
Our analysis of representative ST8 isolates from different
continents puts previous findings about the regional epidemiol-
ogy of ST8 and USA300 into a broader context. ST8 isolates
from Europe and Australia were found scattered across our phy-
logeny, with few clusters of closely related isolates, indicating ei-
ther a diverse local population or multiple introductions with
limited spread in the general population. This means that the ST8
Fig. 3. Phylogeographic evolution of S. aureus USA300. The figure shows a subset of the global transmission routes of different ST8 lineages, including
USA300. Different lineages are highlighted in different colors; thick lines represent major transmission events during the evolution of USA300; dotted lines
represent other transmissions. Transmission times are indicated on major routes. For a comprehensive view of all transmission routes, including single isolates,
view Dataset S6 using Google Earth.
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S. aureus population in these continents consists of genetically
diverse isolates that represent both the ancestral ST8 population
as well as strains with apomorphies (i.e., derived characters) like
PVL and ACME. This genetic diversity in European isolates was
also observed in previous studies (16, 17).
In contrast to the European and Australian ST8, isolates from
the Caribbean and from Africa were exclusively found in distinct
“regional” monophyletic branches at distant positions in our
phylogeny. This indicates lower genetic diversity of ST8 S. aureus
in these regions, presumably caused by single introduction events
from outside, followed by local diversification and regional
spread of the respective clone. This might be due to significantly
fewer travel and trade links of SSA countries with other conti-
nents, compared with connections among, for example, Europe
and North America. However, ST8 S. aureus seems to spread
successfully among SSA countries. Due to this “endemic” situ-
ation, we find locally evolved African ST8 clones that sub-
stantially differ from ST8 clones isolated in other regions: e.g.,
“wild-type” cap5D MSSA.
On the other hand, African USA300-like isolates were found
to be very similar to North American USA300 isolates. Although
the classical USA300 clone belongs to spa-type t008, some North
American USA300 have been identified as spa-type t121 (45).
Probably by chance, one isolate with this more unusual spa-type
was imported to Africa and further evolved locally (founder ef-
fect). Consequently, most African USA300 isolates identified
today either belong to spa-type t121 or to spa-type t112, which
presumably evolved from t121 by duplication of the second spa
repeat. In contrast to Europe, where it was repeatedly shown
that imported USA300 isolates from overseas spread only very
slowly and limitedly in the general population (16, 17),
USA300 in Africa seems to have successfully spread in the local
communities; at this point, we can only speculate whether this
success is related to the unique nonsynonymous SNPs of the
African USA300 isolates (Table 1). This is also indicated by the
monophyletic subgroup of African USA300 isolates in our phy-
logeny (Fig. 2) and is emphasized by a suggested increase of the
proportion of USA300 among MRSA carriers in the Gabonese
population (34, 36), which is in contrast to an only marginal in-
crease of the proportion of USA300 in Germany from 0.1% in
2004 to 0.6% in 2010/2011 (46). One USA300 isolate isolated in
Switzerland (17) and epidemiologically related to Sierra Leone
turned out to be more likely of European origin because it possesses
a “non-African” spa-type and does not fall into the same mono-
phyletic clade as the other nine African USA300 isolates. This is a
good example of how WGS on global collections may help to fa-
cilitate epidemiological reconstructions and outbreak surveillance in
the future. For example, detailed knowledge about regionally cir-
culating sublineages enables an early detection of newly emerging
clones. Moreover, WGS-based typing as a highly discriminatory
method is capable of detecting clonal transmissions and facilitates
the elucidation of potential transmission routes (47, 48).
Our results present both a temporal and spatial bias because
concurrent representative isolates from all regions were not
available, and the inclusion of additional isolates may shift the
results regarding the origin and evolution of USA300 and ST8.
However, vital timings in our analyses (Fig. S1) share a large
resemblance to other studies focusing on the acquisitions of
ACME, COMER, and PVL (15, 27). Similarly, the exclusive
inclusion of an older isolate from Denmark could be reflected in
the phylogeographic results that strongly indicated a Danish
origin of ST8.
In conclusion, our phylogenomics analysis indicates that the
origin of the epidemic USA300 clone lies in the mid-19th century
ST8-MSSA population in Central Europe (Denmark). A cap5D
mutated ST8-MSSA was exported to the United States in the
early 20th century and progressively acquired PVL, ACME/
COMER, SCCmec IVa/c, and cap5E Asp75Tyr within North and
South America, and eventually spread to other continents. The
existence of USA300-NAE in Africa has now been confirmed,
despite unusual spa-types. It is important to conduct further
studies about the factors contributing to the variable success of
USA300 in different geographic regions to contain the health
threat caused by this hypervirulent CA-MRSA clone.
Materials and Methods
Selection of Bacterial Isolates. Our dataset includes a diverse subset of all S.
aureus ST8 WGS sequences available in public databases until November
2015, without including all available USA300 genomes from the United
States. It was completed by in-house Illumina shotgun-sequenced published
isolates from diverse countries of sub-Saharan Africa, Western Australia,
Trinidad and Tobago, and diverse European countries. Our isolates represent
the previously reported diversity of ST8 (49). Even upon request, no
ST8 isolates from Asian countries were available.
In total, 224 human ST8 S. aureus from the United States (n = 57), South
America (n = 28), Australia (n = 14), Europe (n = 43), the Caribbean (n = 18),
and Africa (n = 64) were analyzed by whole genome sequencing (WGS)
(Table 2). The time span of the isolate collection ranges from 1957 to 2013.
Twenty-two samples collected from patients in Switzerland were previously
associated with overseas travel or immigration (17) and were treated
according to their potential country of origin in all analyses.
Isolates from North and South America comprised a selection of published
ST8 S. aureus genomes from two large phylogenetic studies by Planet et al. (n =
42) (27) and Uhlemann et al. (n = 24) (50). These studies represent the genetic
diversity of USA300-NAE and -SAE and were complemented with some non-
USA300 North American ST8. No extensive WGS study covering the diversity
of ST8 was available from South America. Moreover, we were not able to in-
clude early isolates of aboriginal Canadians (51). Two NCBI reference genomes
of USA300-NAE and one of USA500 were included (USA300_TCH1516,
NC_010079.1; USA300_FPR3735, NC_007793.1; USA500_2395, NZ_CP007499.1).
Isolates from Australia comprised one early ST8 CA-MRSA collected in
1989 in a remote aboriginal community in Western Australia (23–25) and
13 diverse ST8 isolates, including PVL- and ACME-positives, isolated between
2003 and 2011 (24, 52).
European isolates mainly included representative isolates of the
CC8 phylogeny (49) and were supplemented by six ST8 genomes from Ger-
many (53) and three USA300 genomes from Switzerland (17). To increase the
temporal span of the collection, 12 “historic” ST8 bacteremia isolates from
Denmark isolated between 1957 and 1997 were added (all except one were
isolated between 1957 and 1973).
The Caribbean samples comprised 17 diverse ST8 S. aureus isolates from
Trinidad and Tobago, including PVL-positive ST8-MSSA and USA300 (29),
and one USA300 isolate with epidemiological link to Cuba, which was iso-
lated in Switzerland (17).
Table 1. Unique nonsynonymous SNPs within the 15 African USA300 clade isolates
SNP position (locus tag)* Gene product SNP Substitution
328599 (SAUSA300_RS01475) DUF5079 domain-containing protein G → A Glu 213 Lys
992391 (SAUSA300_RS04860) Hypothetical protein A → G Val 172 Ala
2232409 (SAUSA300_RS11400) Threonylcarbamoyl-AMP synthase C → T Ala 236 Thr
2648462 (SAUSA300_RS13595) MFS transporter G → A Pro 356 Leu
2779237 (SAUSA300_RS14285) Arginine-ornithine antiporter T → G Ile 30 Leu
*SNP localizations, locus tags, and gene products were given with reference to the genome of strain
USA300_FPR3757 (GenBank accession no. NC_007793).















The African isolates included 10 MRSA isolates previously defined as
USA300-like from Cameroon (n = 1) (33), Gabon (n = 6) (34–37), Ghana (n =
1) (38), and Sierra Leone (n = 1) (17) and 54 diverse ST8 MRSA and MSSA
samples from different African countries from various small-scale studies
(Table 2).
Ethical Statement. This study was performed in accordance with guidelines
approved by the Ethical Committee of the Medical Faculty of the Uni-
versity of Münster and of the Aerztekammer WestfalenLippe. Our in-
stitutional review board waived the need for written informed consent
from the participants.
Table 2. Origin of the 224 included S. aureus isolates
Global region (n isolates total)




isolates Reason to include
Genome sequenced
for this study Source
Africa (64)
Cameroon 2007 1 African background ST8 Yes (33)
Cameroon 2013 1 Global USA300 No (17)
DR Congo 2011 10 African background ST8 Yes (65)
Gabon 2005 1 USA300-like Yes (34)
Gabon 2005 1 USA300-like Yes (37)
Gabon 2008 to 2012 7 African background ST8 Yes This study*
Gabon 2009 4 African background ST8 Yes (66)
Gabon 2009 to 2012 4 USA300-like Yes (36)
Gabon 2009 to 2012 3 African background ST8 Yes (36)
Gabon 2012 2 African background ST8 No (53)
Gabon 2013 1 USA300-like Yes (35)
Gabon 2013 3 African background ST8 Yes (35)
Ghana 2011 1 USA300-like Yes (38)
Ghana 2005 1 African background ST8 Yes This study†
Côte d’Ivoire 2005 10 African background ST8 Yes (65)
Madagascar 2007 1 African background ST8 Yes (33)
Mozambique 2012 1 African background ST8 No (53)
Nigeria 2005 7 African background ST8 Yes (67)
Nigeria 2007 2 Phylogeny of CC8 Yes (49)
Sierra Leone 2013 1 Global USA300 No (17)
Tanzania 2011 2 African background ST8 No (53)
Australia (14)
Australia 1989 1 First ST8 CA-MRSA Yes (23)
Australia 2004 to 2006 6 Global ST8 diversity Yes (24)
Australia 2003 to 2008 4 Global ST8 diversity Yes (52)
Australia 2008 to 2011 3 Global ST8 diversity Yes This study‡
Caribbean (18)
Trinidad & Tobago 2012 17 Global ST8 diversity Yes (29)
Cuba 2013 1 Global USA300 No (17)
Europe (43)
Austria 2005 to 2006 3 Phylogeny of CC8 Yes (49)
Denmark 1957 to 1973 12 Temporal collection Yes This study†
Germany 2010 to 2011 6 Global ST8 diversity No (53)
Germany 2003 to 2008 18 Phylogeny of CC8 Yes (49)
South America (28)
Bolivia 2013 1 Global USA300 No (17)
Brazil 2013 1 Global USA300 No (17)
Colombia 2006 to 2007 13 USA300 NAE/SAE No (27)
Colombia 2006 to 2007 2 Global ST8 diversity No (27)
Colombia 2013 6 Global USA300 No (17)
Ecuador 2006 2 USA300 NAE/SAE No (27)
Ecuador 2013 2 Global USA300 No (17)
Uruguay 2013 1 Global USA300 No (17)
North America (United States) (57)§
FL, HI, IL, IN, MA, MS, MT, PA, SC, NY 2001 to 2012 17 USA300 NAE/SAE No (27)
NY 2008 to 2011 17 USA300 NAE/SAE No (50)
FL, MA, MS, TX, NY 1999 to 2011 8 Global ST8 diversity No (27)
NY 2008 to 2010 7 Global ST8 diversity No (50)
NY 1996 1 USA500 reference genome No (68)
CA 2000 1 USA300 reference genome No (69)
TX 2003 1 USA300 reference genome No (70)
Unknown 2003, 2013 5 Global USA300 No (17)
*Bacterial isolates obtained from the routine microbiology laboratory at the Albert Schweitzer Hospital in Lambaréné, Gabon.
†Bacterial isolates were obtained from the S. aureus national surveillance unit at Statens Serum Institut, Copenhagen.
‡Bacterial isolates were obtained from the Australian Collaborating Centre for Enterococcus and Staphylococcus, Murdoch University, Murdoch, Australia.
§FL, Florida; HI, Hawaii; IN, Indiana; MA, Massachusetts; MS, Mississippi; MT, Montana; PA, Pennsylvania; SC, South Carolina; NY, New York; TX, Texas.
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Whole Genome Sequencing and Genome Analysis. Available WGS data from
previous studies (n = 102) were retrieved in the form of assembled sequences
(contigs) from NCBI GenBank or as reads from the NCBI Sequence Read
Archive (SRA) or European Nucleotide Archive (ENA). They were included
into our dataset provided they passed our internal WGS quality controls: i.e.,
confirmed affiliation to ST8 by in silico MLST and identification of ≥95% of
1,861 core genome MLST (cgMLST) targets (54). The remaining isolates (n =
122) were sequenced using Illumina technology and Nextera XT version
2 chemistry, either with 150-bp or 250-bp paired-end protocols on a NextSeq
500 or MiSeq sequencer (Illumina). All newly generated reads were de-
posited at ENA under study accession no. PRJEB14816. Quality trimming of
fastq files (average base quality of 30, aiming for 100-fold coverage) and de
novo assembly using Velvet 1.1.04 (55) were performed with SeqSphere+
(version 3.1; Ridom GmbH) as described recently (56). Only genomes that
harbored ≥95% cgMLST targets passed the quality control; otherwise, se-
quencing was repeated until the criterion was met. Identification of
USA300-characteristic genes and their allelic variants was performed using a
BLAST search with ≥95% nucleotide identity and ≥99% length coverage
against all nucleotide sequences listed in Dataset S2. SCCmec types were
determined by the BLAST-based detection of specific SCCmec typing primer
sequences (57, 58) and different combinations of cassette chromosome
recombinases (ccr) gene complexes and the mec gene complex, according to
the definitions of the International Working Group on the Staphylococcal
Cassette Chromosome elements (IWG-SCC; www.sccmec.org) (Dataset S3).
PVL-Phage Identification. All de novo assembled genomes positive for both
PVL genes, i.e., lukF-PV and lukS-PV (n = 120), were screened for the pres-
ence of any of the seven phages known to carry the PVL genes (59, 60): (i)
ϕ2958PVL (NC_011344.1, 47,342 bp), (ii) ϕPVL (NCBI GenBank accession
no. AB009866.2, 41,401 bp), (iii) ϕPVL108 (NCBI GenBank accession no.
NC_008689.1, 44,857 bp), (iv) ϕPVL-CN125 (NCBI GenBank accession
no. FJ713816.1, 44,492 bp), (v) ϕSa2USA (NCBI GenBank accession no.
KX130855.1, 5,189 bp), (vi) ϕSaMW2 (NCBI GenBank accession no. BA000033.2,
45,550 bp), and (vii) ϕSLT (NCBI GenBank accession no. NC_002661.2,
42,942 bp). Only ϕSa2USA was found in the de novo assembled isolates. Sub-
sequently, to determine whether the phage was inserted at the same position
in all isolates, we created a 5,787-bp reference sequence comprising the
ϕ2SaUSA phage region plus additional 300 3′ and 5′ flanking nucleotides of
USA300 RefSeq FPR3757 (NC_007793.1) and mapped all available reads of lukF/
S-PV positive isolates (n = 66) against it. Reference mapping was conducted
with CLC Genomics Workbench 8.5.1 (CLC Bio; Qiagen) using default parame-
ters, with the exception of a length fraction value of “0.8” and a similarity
fraction value of “0.95.” No reads (only contigs) were available for public iso-
lates from refs. 17 and 27 (n = 54).
Single Nucleotide Polymorphism and Phylogenetic Analysis. The WGS fastq
data of 121 isolates were aligned against the chromosome of the S. aureus
TCH1516 ST8 reference genome (GenBank accession no. CP000730) using the
short-read alignment component of the Burrows–Wheeler Aligner (BWA) af-
ter removal of duplicated regions identified using NUCmer. Additionally,
103 fasta files containing contigs of the remaining isolates were aligned using
MUMmer/Nucmer. Each alignment was analyzed for single nucleotide poly-
morphisms (SNPs) using NASP (https://github.com/TGenNorth/NASP). If either
the minimum coverage of 10 was not met, or if the variant was present
in <90% of the base calls, the respective SNPs were excluded. Indications of
putative horizontal gene transfer events were defined as a unique SNPs cluster
(≥3) in the NASP output and purged from the alignment. The concatenated
sequence of SNPs can be found in Dataset S4. Based upon the purged SNP
alignment, a phylogenetic tree was constructed using the maximum-likelihood
algorithm implemented in PhyML (61) with Smart Model Selection (SMS) and
the Bayesian Information Criterion (BIC) with 100 bootstrap replicates. For
rooting, the chromosome of S. aureus isolates MW2 (ST1) (GenBank accession
no. BA000033) was used as it represents a closely related outgroup to ST8 (62)
(Fig. S2). The ML phylogeny, including each sample’s association with USA300-
characteristic genes, was visualized using itol.embl.de/.
Ancestral Dating and Phylogeographic Analysis. To explore the timing of di-
versification events, we used coalescence-based analyses to investigate
evolutionary rates and timing of common ancestors using duplicate runs in
BEAST v1.8.2 (63) at CIPRES Science Gateway (64,) (https://www.phylo.org).
We compared the results of different models, including the general-time
reversible (GTR) and the Hasegawa–Kishino–Yano (HKY) substitution mod-
els, under the assumption of both strict and relaxed molecular clock and
different demographic models: i.e., Bayesian skyline, constant population,
and exponentially growing population tree priors. For each analysis,
200 million steps were performed, and the chain was sampled every
20,000th step. The first 10% of each chain was discarded as burn-in. The best
model was chosen based on the highest effective samples size (ESS) and
Bayes factor (BF) values, resulting in the HKY, strict clock, constant pop-
ulation size model with uniform clock rate ([0,1], initial = 0.001). Data were
analyzed with Tracer v1.6 and TreeAnnotator v1.8.2. The maximum clade
credibility tree was visualized using FigTree v1.4.2.
A Bayesian analysis was also conducted to determine the most likely
geographical origin of the most recent common ancestors (MRCAs) using an
HKY, strict clock, constant population size model with uniform clock rate
([0,1], initial = 0.001) and a Markov chain Monte Carlo (MCMC) length of
120 million steps, with chain sampling every 10,000th step and burn-in at
10%. Taxa groups were defined for monophyletic groups of interest: e.g.,
USA300-NAE, USA300-SAE, or basal-African based on the ML data. Detailed
parameters are provided in Dataset S5. Again, the analysis was run in BEAST
v1.8.2 at CIPRES Science Gateway. The geographic origin of the entire
dataset based on the .root BEAST output file was determined according to
the instructions provided at bedford.io/projects/dynamics-practical/examine-
the-phylogeographic-output.html (accessed April 2016). The maximum clade
credibility (mcc) tree was calculated with TreeAnnotator v.1.8.2 and used for
graphical representation of the data. A .kml file to visualize the phylogeo-
graphic spread using Google Earth was created from the mcc tree using the
phylogeo.jar script developed by Trevor Bedford (https://github.com/trvrb/
dynamics-practical/tree/master/scripts, accessed April 2016) (Dataset S6).
Identification of Genetic Markers. We searched for the presence or absence of
genes and unique nonsynonymous SNPs that might be associated with the
evolutionary success of the twoUSA300 lineages (USA300-NAE andUSA300–SAE)
and the African USA300 clade. Therefore, we screened the genomes of all
USA300-NAE isolates present in our dataset (n = 74) and the genomes of two
closely related ST8 outgroup isolates (USA_2009_11 and USA_2009_12) for the
presence of USA300-NAE core genome genes, including all single copy genes
(genes with fragments that occur in multiple copies with an identity of ≥90%
and >100-bp overlap were excluded) with a minimal length of 50 bp of NCBI
RefSeq USA300 genome FPR3757 (NC_007793.1; 2,804 targets in total) (Dataset
S7). Similarly, we screened the genomes of all USA300-SAE isolates of our
dataset (n = 35) and the two outgroup strains for the presence of USA300-SAE–
specific core genome genes derived from strain M121 (CP007670.1; 2,550 targets
in total) (Dataset S7). Moreover, to identify the absence of genes in USA300, we
screened both USA300-NAE and USA300–SAE isolates for the presence of core
genome genes of one of the outgroup strains (strain C1768, GenBank accession
no. LAMT01000000, syn. USA_2009_11; 2,678 targets in total) (Dataset S7).
Candidate genes for USA300-specific yet unknown genetic markers were iden-
tified by either being present in all USA300-NAE or USA300–SAE isolates from
our collection and absent in the outgroup, or being absent in all USA300-NAE or
USA300–SAE isolates and present in both outgroup strains. The resulting can-
didate genes were subsequently queried against all other ST8 sequences of our
dataset (n = 113). For the African USA300 clade, we performed the same pro-
cedures using isolate Gabon_2009_1 (this study, 2,643 targets in total) (Dataset
S7) as representative for the African USA300 clade. The analyses were conducted
with the aid of the SeqSphere+ software.
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